CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Subscription Receivables	Accumulated Deficit	Total
Balance at the beginning at Dec. 31, 2023	$ 4	$ 381,264	$ (60,710)	$ (473,602)	$ (153,044)
Balance at beginning (in shares) at Dec. 31, 2023	516,404
Net Income (Loss)				39,923	39,923
Termination of Forward Purchase Agreements			$ 60,710		60,710
Issuance of shares and reclassification of liability related to cashless warrant exercises		14,979			$ 14,979
Issuance of shares and reclassification of liability related to cashless warrant exercises (in shares)	27,310				27,310
Issuance of shares related to at-the-market offering, net		50			$ 50
Issuance of shares related to at-the-market offering, net	916
Issuance of common stock		384			384
Issuance of common stock (in shares)	5,556
Stock-based compensation expense		4,908			4,908
Balance at the ending at Sep. 30, 2024	$ 4	401,585		(433,679)	(32,090)
Balance at ending (in shares) at Sep. 30, 2024	550,186
Balance at the beginning at Jun. 30, 2024	$ 4	399,557		(427,508)	(27,947)
Balance at beginning (in shares) at Jun. 30, 2024	543,714
Net Income (Loss)				(6,171)	(6,171)
Issuance of shares related to at-the-market offering, net		50			50
Issuance of shares related to at-the-market offering, net	916
Issuance of common stock		384			384
Issuance of common stock (in shares)	5,556
Stock-based compensation expense		1,594			1,594
Balance at the ending at Sep. 30, 2024	$ 4	401,585		(433,679)	(32,090)
Balance at ending (in shares) at Sep. 30, 2024	550,186
Balance at the beginning at Dec. 31, 2024	$ 4	403,024		(431,597)	$ (28,569)
Balance at beginning (in shares) at Dec. 31, 2024	555,511				555,511
Net Income (Loss)				(2,085)	$ (2,085)
Issuance of shares and reclassification of liability related to cashless warrant exercises	$ 5	6,884			6,889
Issuance of shares and reclassification of liability related to cashless warrant exercises (in shares)	10,869,856
Issuance of shares related to at-the-market offering, net		168			168
Issuance of shares related to at-the-market offering, net	218,419
Stock-based compensation expense		3,725			3,725
Balance at the ending at Sep. 30, 2025	$ 9	413,801		(433,682)	$ (19,872)
Balance at ending (in shares) at Sep. 30, 2025	11,643,786				11,643,786
Balance at the beginning at Jun. 30, 2025	$ 9	413,283		(429,144)	$ (15,852)
Balance at beginning (in shares) at Jun. 30, 2025	11,537,870
Net Income (Loss)				(4,538)	(4,538)
Issuance of shares and reclassification of liability related to cashless warrant exercises		20			20
Issuance of shares related to at-the-market offering, net		84			84
Issuance of shares related to at-the-market offering, net	105,916
Stock-based compensation expense		414			414
Balance at the ending at Sep. 30, 2025	$ 9	$ 413,801		$ (433,682)	$ (19,872)
Balance at ending (in shares) at Sep. 30, 2025	11,643,786				11,643,786